Berkeley Catalyst Fund (BCF) is an investment Firm.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
The Berkeley Catalyst Fund (BCF) provides benefits to entrepreneurial startups and helps foster the vibrant startup ecosystem around the UC systems located in the San Francisco Bay Area. BCF invests primarily in Seed and Series A stage private companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2018 | DNALite Therapeutics | Seed Round | 0 |
4/2017 | LogicInk | Pre Seed Round | 1M |
9/2021 | Acrigen Biosciences | Seed Round | - |
8/2018 | Newomics | Series A | 3.9M |
1/2021 | Resilient Biotics | Series A | 7.2M |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
3/2022 | Arima Genomics | Series B | 0 |
12/2020 | Newomics | Series B | 0 |
2/2020 | Arima Genomics | Series A | - |
12/2019 | Akadeum Life Sciences | Series A | - |
10/2021 | Akadeum Life Sciences | Series B | 0 |
1/2023 | Telesair | Series A | 22M |
8/2020 | Syntegra | Seed Round | 0 |
9/2018 | Valitor | Series A | 0 |
4/2020 | Nelumbo | Series A | 14M |
10/2022 | Valitor | Series B | 0 |
3/2020 | SwineTech | Series A | 0 |
12/2020 | PrinterPrezz | Series A | 16M |
7/2022 | Vicinitas Therapeutics | Series A | 65M |
7/2018 | Nelumbo | Series A | 0 |
3/2021 | Amplicore | Seed | 4M |
3/2020 | Circle Pharma | Series B | 0 |
7/2022 | Vicinitas Therapeutics | Series A | 0 |
3/2022 | Arima Genomics | Series B | 0 |
10/2021 | Akadeum Life Sciences | Series B | 0 |
9/2021 | Acrigen Biosciences | Seed Round | - |
3/2021 | Amplicore | Seed Round | 0 |
1/2021 | Resilient Biotics | Series A | 0 |
12/2020 | PrinterPrezz | Series A | 0 |
12/2020 | Newomics | Series B | 0 |
8/2020 | Syntegra | Seed Round | 0 |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|